NSE · PAR
Par Drugs And Chemicals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,598
of 5,072 stocks
▼ 161W
Peak #2,582 · 21 Sep 2026
Par Drugs And Chemicals Limited, a microcap Healthcare business, remains firmly promoter-controlled, with promoters holding 73%, is growing revenue modestly, and trades at a moderate earnings multiple.
Market Cap
161.69 Cr
P/E Ratio
12.34
P/B Ratio
1.44
ROE
11.71%
ROCE
15.09%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 31.28 Cr | 19.61 Cr | 29.34 Cr | 28.66 Cr |
| Net Profit | 4.71 Cr | 85.36 L | 4.80 Cr | 4.13 Cr |
| EPS | 3.83 | 0.69 | 3.90 | 3.36 |
| Operating Profit | 6.35 Cr | 87.29 L | 6.46 Cr | 5.61 Cr |
Shareholding pattern
Promoter
73.41%
Public
26.59%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 23 Dec 2024 | Other | Extra Ordinary General Meeting |
| 13 Sep 2024 | Other | Annual General Meeting |
| 08 Sep 2023 | Other | Annual General Meeting |
| 01 Sep 2022 | Other | Annual General Meeting |
| 22 Nov 2021 | Dividend | Interim Dividend - Rs 1.25 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.